De-escalating chemotherapy for stage II colon cancer?

Jianfei FuLunpo WuChenyang GeTiantian XuDan LiWei FuLiang-Jing Wang Jinlin Du

Published in: Therapeutic advances in gastroenterology (2019)

The value of chemotherapy is much less than we thought. It is time to de-escalate chemotherapy for stage II colon cancer. CCSD, rather than overall survival, should be considered as an appropriate primary end point for future trials in stage II colon cancer.

Keyphrases

locally advanced
chemotherapy induced
rectal cancer
radiation therapy
current status